Niche market Indose operates at the intersection of medical devices and cannabis, offering the first medicinal device that measures dosage in real-time. This indicates sales opportunities with cannabis product manufacturers seeking precise dosing tools and regulatory-focused buyers in medical cannabis markets.

High value proposition The device provides milligram-level dosage accuracy and real-time display, a compelling differentiator for premium cannabis brands and medical patients who require controlled dosing, suggesting potential upsell to device-enabled product lines and pharmacopoeia-aligned partnerships.

Early funding signals Recent Series A funding led by Casa Verde implies investor confidence and potential credibility with distribution partners, retailers, and clinics. Leverage this to open introductions to cannabis processors, medical distributors, and telehealth channels.

Small team, outsized reach With a lean team and revenue under one million dollars, focus sales on strategic B2B partnerships, white-label opportunities, and OEM collaborations to accelerate go-to-market and reduce customer acquisition costs.

Technology stack Cloud infrastructure and web-based platforms (AWS, Webflow, WordPress) support scalable digital engagement; pursue integrations with cannabis POS systems, patient portals, and EHR-like workflows to streamline ordering, dosing data, and compliance reporting.